Clinical Trial Update: A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1 [Phase 4]

View source ↗

Summary

A Phase 4 HIV trial comparing saquinavir plus lopinavir/ritonavir with enfuvirtide to saquinavir plus lopinavir/ritonavir with other nucleoside backbones was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Enfuvirtide (enfuvirtide)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• Saquinavir (saquinavir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infection | Phase 4 | Status: TERMINATED